Showing 1 to 10 of 20
| Title | Consultation | Type | Consultation end date | Sort date |
|---|---|---|---|---|
| Volanesorsen for treating familial chylomicronaemia syndrome [ID1326] | Evaluation consultation: 1 | Highly specialised technology | Type:27 January 2020 | 20200127 |
| Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID1504] | Appraisal consultation | Technology appraisal guidance | Type:28 January 2020 | 20200128 |
| Tobacco: preventing uptake, promoting quitting and treating dependence (update) | Call for evidence | NICE guideline | Type:30 January 2020 | 20200130 |
| Indoor air quality at home | Topic engagement | Quality standard | Type:31 January 2020 | 20200131 |
| Deep brain stimulation for refractory epilepsy | Interventional procedure consultation | Interventional procedures guidance | Type:04 February 2020 | 20200204 |
| Transcranial magnetic stimulation for obsessive-compulsive disorder | Interventional procedure consultation | Interventional procedures guidance | Type:04 February 2020 | 20200204 |
| Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant [ID1508] | Appraisal consultation | Technology appraisal guidance | Type:04 February 2020 | 20200204 |
| Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke | Diagnostics consultation: 2 | Diagnostics guidance | Type:04 February 2020 | 20200204 |
| Rehabilitation in adults with complex psychosis and related severe mental health conditions | Draft guidance consultation | NICE guideline | Type:05 February 2020 | 20200205 |
| Pembrolizumab for untreated metastatic or unresectable recurrent squamous cell head and neck cancer [ID1140] | Appraisal consultation | Technology appraisal guidance | Type:05 February 2020 | 20200205 |